Fiscal year ending 2023. Filed on May 14, 2024.
300 Conshohocken State Road 420
West Conshohocken, Pennsylvania 19428
Transcelerate Biopharma Inc. (EIN: 46-0886344) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2023 IRS Form 990 filing, Transcelerate Biopharma Inc., a 501(c)(6) business league, reported compensation for 10 out of 34 total employees. Among the employees shown here, the average compensation is $829,424. The highest compensated employee at Transcelerate Biopharma Inc. is Dalvir Gill with fiscal year 2023 compensation of $2,534,948.
Revenue
Expenses
Employee compensation
THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.
Be the first to know when new IRS Form 990 data is published for this organization.